(Q43993916)

28 November 2017

title

Topoisomerase II-alpha expression in different cell cycle phases in fresh human breast carcinomas (English)

1 reference

28 November 2017

5

1 reference

28 November 2017

Kenneth Villman

1

1 reference

28 November 2017

Elisabeth Ståhl

series ordinal

2

1 reference

28 November 2017

Göran Liljegren

series ordinal

3

1 reference

28 November 2017

Ulf Tidefelt

series ordinal

4

1 reference

28 November 2017

publication date

1 May 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

15

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

486-491

1 reference

28 November 2017

cites work

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880552

The mechanisms of DNA topoisomerases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880552

DNA topoisomerase poisons as antitumor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880552

Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880552

DNA topoisomerases: essential enzymes and lethal targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880552

Antitopoisomerase drug action and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880552

Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880552

Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880552

Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880552

Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880552

A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880552

The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880552

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880552

Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880552

Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880552

7 January 2021

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880552

7 January 2021

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880552

7 January 2021

Interphase cytogenetic analysis of erbB2 and topoII alpha co-amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880552

7 January 2021

10.1038/MODPATHOL.3880552

Identifiers

DOI

1 reference

Dimensions Publication ID

28 November 2017

1023125302

0 references

1 reference